Taiwan Emerges as Central Flashpoint in TrumpXi Talks Microsoft and Anthropic Discuss Custom AI Chip Deal Amidst Strategic Investments Jim Cramer Weighs In on Analog Devices Market Position in Semiconductor Sector AMD Commits Over 10 Billion to Taiwan AI Market Expanding Chip Production and Partnerships AI Consultants Charge Wall Street Banks 25000 Daily for Expertise SGX RegCo Proposes ThreeYear Limit for Suspended Companies to Resume Trading or Face Delisting MCHP Q1 2026 Earnings EPS Surges Past Estimates by 106 Amid Solid Operational Execution GEG Q1 2026 Earnings Substantial EPS Miss Triggers Stock Decline Seanergy Maritime Holdings Corp SHIP Q4 2025 Earnings Strong EPS Beat Amid Dry Bulk Sector Headwinds VOYG Q1 2026 Earnings EPS Misses Estimates Stock Rallies Edesa Biotech Inc EDSA Q1 2026 Earnings Wider Than Expected Loss as Clinical Pipeline Progresses Inflection Point Acquisition Corp III Rights IPCXR Edges Higher Amid Modest Trading Activity Avient Corporation AVNT Holds Steady Above Support After Modest Gain Jiuzi Holdings JZXN Edges Higher as Stock Tests Key Resistance Levels Title Civeo Corporation CVEO Edges Higher Testing Key Resistance Near 372 Nuveen Municipal Credit Income Fund NZF Holds Steady Near Resistance as Income Seekers Eye Yield Market Wrap Nifty Sensex Edge Higher on May 22 JSW Cement Honasa Consumer Among Leaders United Community Banks Inc UCB Q1 2026 Earnings EPS Slightly Misses Estimates Stock Edges Lower MapLight Therapeutics Rises 24 Nearing Key Resistance Level MPLT RGA Q1 2026 Earnings Strong EPS Beat Driven by Favorable Underwriting Results HSLV Q1 2026 Earnings Massive EPS Surprise of 1645 Despite No Revenue Stock Slips 2 Universal Logistics Holdings ULH Q1 2026 Earnings Significant EPS Miss Amid Revenue Uncertainty Stock Gains 34 Vicor Corporation VICR Q1 2026 Earnings EPS Surges Past Estimates by Nearly 20 WWR Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Graphite Development CECO Q1 2026 Earnings Massive EPS Beat Drives Stock Rally AIM ImmunoTech Q1 2026 Earnings EPS Miss Widens as Clinical Pipeline Drives Higher Operating Costs